NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines
Greater Glasgow and Clyde Medicines
Posted: February 20, 2018.
Category - Medicines Update
There have been recent incidents across GG&C involving 48 hourly IV gentamicin which was prescribed a day in advance and subsequently administered 24 hours earlier than intended. This may potentially lead to gentamicin toxicity ...
Posted: February 19, 2018.
Category - Medicines Update
The NHSGGC Guideline on Orthopaedic Thromboprophylaxis for Patients Admitted to Hospital has been reviewed and updated. This is now available on the Clinical Guideline Repository on Staffnet
Posted: February 19, 2018.
Category - Medicines Update
Our NEW Medicine Supply Pro...
Posted: February 19, 2018.
Category - Medicines Update
Key points SSRIs (selective serotonin reuptake inhibitors) and SNRIs (serotonin noradrenaline reuptake inhibitors) are associated with a risk of bleeding, especially upper GI bleedingThe risk of GI bleeding ...
Posted: February 19, 2018.
Category - Medicines Update
Key messages: Lithium is a gold standard treatment for maintenance treatment of bipolar affective disorder Lithium has a high potential for toxicity and requires careful monitoring to ensure its safe and...
Posted: January 29, 2018.
Category - Medicines Update
The Therapeutics Handbook content has now been updated and includes the following main changes: Drug Overdose and Toxicity
Posted: January 19, 2018.
Category - Medicines Update
The NHSGGC Antimicrobial Management Team have published guidance on the use of antivirals for influenza. This guidance includes a link to the Public Health England guidance which has been approved for use in Scotland by the Scottish Health...
Posted: January 19, 2018.
Category - Medicines Update
The following is a message from Yellow Card Scotland: ‘’The Yellow Card (YC) reporting data for Scotland for the Year 2016-17 is now available in our
Posted: January 19, 2018.
Category - Medicines Update
LHRH agonists have an important role in the management of prostate cancer. Within NHSGGC, leuprorelin (Prostap® DCS brand) is the medicine of choice for new patients where castration therapy with an LHRH agonist i...
Posted: January 19, 2018.
Category - Medicines Update
Key messages Eplerenone and spironolactone are mineralocorticoid receptor antagonists (MRAs) Combining ACEI (or ARB) with MRA in patients with HF due to reduced LVEF improves major outcomes C...